Subscribe: Market Wire - Pharmaceuticals and Biotech: Equipment and Supplies
Preview: Market Wire - Pharmaceuticals and Biotech: Equipment and Supplies

Marketwired - Equipment and Supplies

Marketwired - Equipment and Supplies

Last Build Date: Fri, 22 Sep 2017 17:02:19 EDT

Copyright: Copyright: (C) Marketwired

Rennova Health, Inc. Announces Reverse Stock Split

Fri, 22 Sep 2017 16:30:00 EDT

WEST PALM BEACH, FL--(Marketwired - September 22, 2017) - Rennova Health, Inc. (NASDAQ: RNVA) (NASDAQ: RNVAZ) today announced that effective at 5:00 pm, Eastern Time, on October 5, 2017 (the "Effective Time"), the Company will effect a 1 for 15 reverse stock split of its outstanding common stock. The Company's common stock will open for trading on The NASDAQ Capital Market on Friday October 6, 2017, on a post-split basis.

Endonovo Therapeutics, Inc. and Kodiak Capital Group, LLC Announce Settlement and Dismissal of Lawsuit

Fri, 22 Sep 2017 13:08:34 EDT

LOS ANGELES, CA--(Marketwired - Sep 22, 2017) -  Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a developer of non-invasive electroceuticals for the treatment of vascular diseases and inflammatory conditions, and Kodiak Capital Group, LLC ("Kodiak"), a private equity firm, today announced a settlement agreement and dismissal of complaints and cross-complaints arising out of a contemplated equity investment by Kodiak in Endonovo.

The Alliance for Regenerative Medicine Submits Letter to Congress Detailing Concerns with the Senate's American Health Care Act

Fri, 22 Sep 2017 13:06:48 EDT

WASHINGTON, DC--(Marketwired - Sep 22, 2017) - The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the gene and cellular therapies and broader regenerative medicine sector, today sent a letter to U.S. Sens. Graham (R-SC), Cassidy, MD (R-LA), Heller (R-NV) and Johnson (R-WI), detailing concerns regarding the American Health Care Act (H.R. 1628).

Amedica Releases First and Second Quarter 2017 Preliminary Unaudited Earnings Report and Business Update

Fri, 22 Sep 2017 09:00:00 EDT

SALT LAKE CITY, UT--(Marketwired - Sep 22, 2017) - Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride for biomedical applications, today announced its preliminary earnings report for the first and second quarters ended March 31, 2017 and June 30, 2017, respectively, and provided a business update related to its business strategy and certain recent developments.

Overcoming the Challenges of Conducting Clinical Studies in Rare Pediatric Populations

Fri, 22 Sep 2017 08:08:27 EDT

TORONTO, ON--(Marketwired - September 22, 2017) - In an upcoming webinar on Wednesday, October 11, 2017 at 11am EDT (4pm BST/UK) experts from PRA Health Sciences including Scott Schliebner, Vice President of Rare Disease - Scientific Affairs, and Mark Sorrentino, MD, Vice President of the Center for Pediatric Clinical Development, will highlight some of the key challenges associated with conducting research within rare pediatric populations that are few in number to begin with, are geographically dispersed and are often not located near a research center.

Beware the Hidden Costs of Conducting Clinical Trials: Understanding the Landmines and How to Avoid Them

Fri, 22 Sep 2017 08:04:06 EDT

TORONTO, ON--(Marketwired - September 22, 2017) - In a complimentary webinar taking place on Wednesday, October 11, 2017 at 11am EDT (4pm BST/UK) experts from Medpace will explore four areas that can dramatically affect the cost and timelines of your clinical program and offer insight into elimination and control of these hidden landmines.

SANUWAVE Health to Attend Upcoming Symposium on Advanced Wound Care (SAWC)

Thu, 21 Sep 2017 16:00:00 EDT

SUWANEE, GA--(Marketwired - Sep 21, 2017) - SANUWAVE Health, Inc. (OTCQB: SNWV) today announces the Company's planned attendance at the Symposium on Advanced Wound Care/Fall (SAWC/Fall), October 20 - 22, 2017 in Las Vegas, NV. The semi-annual SAWC meeting is the premier interdisciplinary wound care program and the largest annual gathering of wound care clinicians in the United States. More than 2,000 physicians, podiatrists, nurses, therapists, researchers, and scientists are expected to attend the 2017 SAWC/Fall meeting.

Realm Therapeutics Announces $26 Million PIPE Financing

Thu, 21 Sep 2017 13:56:47 EDT

MALVERN, PA--(Marketwired - Sep 21, 2017) - Realm Therapeutics plc (AIM: RLM), a clinical stage biopharmaceutical company focused on leveraging its proprietary immunomodulatory technology, is pleased to announce today that it has successfully secured funding commitments to raise gross proceeds of $26 million through a private placement in the United States and the United Kingdom (the "PIPE") to existing and new investors, including healthcare specialist funds OrbiMed, BVF Partners LP, RA Capital Management, Abingworth BioEquities Master Fund Ltd and Polar Capital. The PIPE is conditional upon approval of the Company's shareholders, to whom it is being presented at a General Meeting expected to be held in London on October 9, 2017, and other customary closing conditions.

Marijuana Company of America Announces Update on Hemp Growing Trials in Canada

Thu, 21 Sep 2017 13:51:01 EDT

ESCONDIDO, CA--(Marketwired - Sep 21, 2017) - MARIJUANA COMPANY OF AMERICA ("MCOA" or the "Company") (OTC PINK: MCOA), in conjunction with its joint venture partner, Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC PINK: GBHPF), is pleased to provide an update on the hemp cultivation trials conducted in New Brunswick, Canada.

AngioSoma, Inc. (OTC: SOAN) Reports Esther & Esther Confident in New Revenue Plan

Thu, 21 Sep 2017 11:33:33 EDT

HOUSTON, TX--(Marketwired - Sep 21, 2017) -  AngioSoma, Inc. (OTC: SOAN) -- Esther & Esther management has high optimism that its revenue plan could prove successful. The publicly stated plan simply and efficiently drives high volume traffic and interested buyers directly to

Eyetronic therapy: New milestone reached with 300 patients treated

Thu, 21 Sep 2017 10:00:00 EDT

Proven optic nerve stimulation can improve field of vision in patients with glaucoma and other optic neuropathies

Spectral Provides Regulatory Update on Its PMA Submission for Toraymyxin(TM)

Thu, 21 Sep 2017 08:00:00 EDT

TORONTO, ONTARIO--(Marketwired - Sept. 21, 2017) - Spectral Medical Inc., (TSX:EDT), a Phase III company developing the first treatment for patients with endotoxemic septic shock, today announced that, pursuant to the acceptance by the United States Food and Drug Administration ("FDA") of its PMA submission for ToraymyxinT for filing on July 20, 2017, it has been engaged in an ongoing interactive review process with the FDA. Based on the filing acceptance date of July 20, 2017, the Company expects to receive more detailed feedback from the FDA on its PMA submission in the fourth quarter of this year.

Pharma Competitive Intelligence: Delivering Actionable Insights for Decision Making, New Webinar Hosted by Xtalks

Thu, 21 Sep 2017 07:30:00 EDT

TORONTO, ON--(Marketwired - September 21, 2017) - In a live webinar taking place on Tuesday, October 10, 2017 at 10am EDT (3pm BST/UK) industry experts Jamie Munro, Global Practice Leader of Portfolio and Licensing and Karthik Subramanian, Senior Product Strategy Manager, both from Clarivate Analytics, will provide insight into current Pharma CI, including trends and best practices.

InspireMD Announces Distribution Agreement for CGuard(TM) EPS in Portugal

Thu, 21 Sep 2017 07:30:00 EDT

TEL AVIV, ISRAEL--(Marketwired - Sep 21, 2017) - InspireMD, Inc. (NYSE MKT: NSPR) (NYSE American: NSPR) (NYSE MKT: NSPR.WS) (NYSE American: NSPR.WS) ("InspireMD" or the "Company"), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced it has signed an agreement with Medicinália Cormédica MC Medical Lda, a leading medical distributor in Portugal, to distribute CGuardT EPS (Embolic Prevention System). Medicinália Cormédica MC Medical Lda is a subsidiary of WerfenLife Company, one of Europe's largest distributors of medical products.

Mayo Clinic Doctor Joins Advanced Medical Isotope Corporation's (ADMD) Medical Advisory Board

Thu, 21 Sep 2017 07:22:00 EDT

RICHLAND, WA--(Marketwired - Sep 21, 2017) - Advanced Medical Isotope Corporation (OTC PINK: ADMD), a late stage radiation oncology focused medical device company strengthened its Medical Advisory Board with the recent addition of Dr. Beau Toskich from Mayo Clinic, who has been informally working with the Company's advisory board for the last six months.

Electronic Informed Consent: 2017 Industry Survey Results from Clinical Sites, New Webinar Hosted by Xtalks

Thu, 21 Sep 2017 07:00:00 EDT

TORONTO, ON--(Marketwired - September 21, 2017) - It's an exciting time for the life sciences industry, with technology driving greater levels of efficiency, effectiveness and patient engagement and satisfaction in clinical trials.

Breathtec Biomedical Announces Resignation of Chief Executive Officer

Wed, 20 Sep 2017 17:05:06 EDT

VANCOUVER, BC--(Marketwired - Sep 20, 2017) -  Breathtec Biomedical Inc. (CSE: BTH) (CNSX: BTH) (FRANKFURT: BTI) (OTCQB: BTHCF) (the "Company") announces that effective immediately, Guy La Torre has resigned as Director and Chief Executive Officer ("CEO") of the Company to pursue other ventures. The Company wishes Guy the best with his future endeavours. An interim CEO will be appointed in due course. 

Savaria annonce la nomination d'un nouveau directeur

Wed, 20 Sep 2017 15:20:25 EDT

LAVAL, QUÉBEC--(Marketwired - 20 sept. 2017) - Savaria Corporation (TSX:SIS) («Savaria» ou la «Société»), un des chefs de file nord-américains de l'industrie de l'accessibilité, est heureuse d'annoncer la nomination de Caroline Bérubé au conseil d'administration de la Société, en vigueur immédiatement. Cette nomination portera à huit le nombre total de membres du conseil, dont cinq sont indépendants.

Savaria Appoints New Director

Wed, 20 Sep 2017 15:19:31 EDT

LAVAL, QUEBEC--(Marketwired - Sept. 20, 2017) - Savaria Corporation (TSX:SIS) ("Savaria" or the "Corporation"), one of North America's leaders in the accessibility industry, is pleased to announce the appointment of Caroline Bérubé to the Board of Directors of the Corporation, effective immediately. The appointment expands the Board to eight directors, five of whom are independent.

Sir Andrew Witty, Former CEO of GSK, Joins Synthego Advisory Board

Wed, 20 Sep 2017 09:03:00 EDT

Synthego strengthens position with appointment while accelerating worldwide commercial growth

SANUWAVE Announces Exhibition at Medica in Cooperation With State of Georgia; Visit us at Booth 16D10-8 in Hall 16

Wed, 20 Sep 2017 09:00:00 EDT

SUWANEE, GA--(Marketwired - Sep 20, 2017) - SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce that the company will exhibit, in conjunction with Georgia Department of Economic Development, at MEDICA in Dusseldorf, Germany on 13 -16 November 2017. SANUWAVE cordially invites you to our section of booth 16D10-8 in Hall 16. MEDICA is the world's leading trade fair for the medical industry. SANUWAVE is using this occasion to further educate on our lead wound care product, dermaPACE® and our industry leader for the treatment of various orthopedic conditions, orthoPACE®.

CFN Media Exclusive Interview with United Cannabis: Developing Anti-Inflammatory Pharmaceuticals

Wed, 20 Sep 2017 09:00:00 EDT

SEATTLE, WA--(Marketwired - Sep 20, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an exclusive interview with United Cannabis Corp.'s (OTCQB: CNAB) Chief Science Officer Dr. Brent Reynolds, PhD. In the interview, Dr. Reynolds discusses the importance of clinical development and how the company's recent acquisition of Prana Therapeutics plays into its overall strategy.

True Leaf: Crowdfunding Legal Cannabis Products Across North America -- CFN Media

Wed, 20 Sep 2017 09:00:00 EDT

SEATTLE, WA--(Marketwired - Sep 20, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article examining True Leaf Medicine International Ltd. (CSE: MJ) (CNSX: MJ) (MJ.CN) (OTCQB: TRLFF) and its pending Regulation A+ public offering that is giving anyone the opportunity to invest in hemp and cannabis products that will be fully legal in both the U.S. and Canada. True Leaf's mission is to create safe, natural cannabis based products that enhance the quality of life for both people and pets. The company already has pet products in the market, and is in the final stages of Canadian approval to grow and sell legal cannabis.

ABcann Global Enters Its Growth Phase (Plus Exclusive Interview) -- CFN Media

Wed, 20 Sep 2017 09:00:00 EDT

SEATTLE, WA--(Marketwired - Sep 20, 2017) -  CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an exclusive interview with ABcann Global Corporation's (TSX VENTURE: ABCN) (OTCQB: ABCCF) Aaron Keay, former CEO and current member of the Board of Directors. In the interview, Mr. Keay discusses the company's transition to new CEO Barry Fishman, as well as the opportunities ahead for the company in both Canada and internationally.

Abattis Prepares for Growth in Extracts -- CFN Media

Wed, 20 Sep 2017 08:30:00 EDT

SEATTLE, WA--(Marketwired - Sep 20, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article discussing Abattis Bioceuticals Corp. (CSE: ATT) (ATT.CN) (CNSX: ATT) (OTCQB: ATTBF) and why its proprietary extraction technology represents an important breakthrough that shouldn't be ignored. While many licensed producers are focused on expanding capacity, the best opportunities may be those that can add value for existing licensed producers. These opportunities include those companies focused on higher value cannabis extracts.

NetworkNewsWire Announces Publication Highlighting Recent Developments in Drug Delivery Technologies

Wed, 20 Sep 2017 08:30:00 EDT

NEW YORK, NY--(Marketwired - Sep 20, 2017) - NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP), a client of NNW that develops and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids.

InMed Pharma: A Leader in Cannabinoid Biosynthesis -- CFN Media

Wed, 20 Sep 2017 08:30:00 EDT

SEATTLE, WA--(Marketwired - Sep 20, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article covering how InMed Pharmaceuticals Inc. (CSE: IN) (CNSX: IN) (IN.CN) (OTCQB: IMLFF) is leveraging biosynthesis to solve a major problem in the medical cannabis industry as it adds key ex-Eli Lilly personnel to its efforts.

Treos Bio Enters into Agreement with PPD to Manage First-in-Man Trial of Its Lead Therapeutic Cancer Vaccine Program

Wed, 20 Sep 2017 08:15:00 EDT

SAN FRANCISCO, CA and LONDON, UNITED KINGDOM--(Marketwired - Sep 20, 2017) - Treos Bio Limited, which is developing precision peptide cancer vaccines coupled with companion diagnostics, today announced it has entered into an agreement with Pharmaceutical Product Development, LLC (PPD), a leading global contract research organization. As part of the agreement, PPD® Biotech, a PPD service dedicated to biotech and small to mid-sized pharmaceutical companies, will manage Treos Bio's first-in-man study of its lead therapeutic cancer vaccine for metastatic colorectal cancer. This study will be conducted in the United States and Europe.

Radient Technologies Inc. Announces Industrial-Scale Capability for the Extraction of Nicotine from Tobacco

Wed, 20 Sep 2017 08:00:00 EDT

EDMONTON, ALBERTA--(Marketwired - Sept. 20, 2017) - In response to a July 28, 2017 U.S. Food and Drug Administration (the "FDA") release in which the FDA states "lowering nicotine levels could decrease the likelihood that future generations become addicted to cigarettes and allow more currently addicted smokers to quit," Radient Technologies Inc. ("Radient") (TSX VENTURE:RTI) is pleased to announce the successful completion of a project to extract nicotine from tobacco at industrial scale.

Strategy Design & Formulation Considerations for GLP Toxicology Studies, New Webinar Hosted by Xtalks

Wed, 20 Sep 2017 07:30:00 EDT

TORONTO, ON--(Marketwired - September 20, 2017) - A lack of planning for a new compound's GLP toxicology study can severely trip up your IND. Upfront planning to design a successful toxicology study, identify problems and allow time for solutions can help avoid costly delays. Toxicology study design requires a customized strategy that is relevant to the intended clinical indication and route of administration and is acceptable to regulatory authorities. Formulation development plays an important role in assessing the in-vivo properties of a molecule during preclinical development, such as overcoming solubility issues and maximizing exposure.

Next Generation Data Mapping and Analytics Solutions Improve the Speed and Quality of Preparing Data Submissions for FDA, New Webinar Hosted by Xtalks

Wed, 20 Sep 2017 07:00:00 EDT

TORONTO, ON--(Marketwired - September 20, 2017) - FDA now requires drug development firms pursuing approvals to submit all clinical data in CDISC standards such as the Study Data Tabulation Model (SDTM). To meet this requirement, many companies are using labor-intensive, manual and error-prone data extraction and mapping techniques.

Dr. Patrick M. Fratellone Joins Canbiola, Inc. (CANB) as Medical Advisor and Distributor

Tue, 19 Sep 2017 10:30:00 EDT

HICKSVILLE, NY--(Marketwired - Sep 19, 2017) - Canbiola, Inc. (OTC PINK: CANB) announced today that the company has added Dr. Fratellone to its Medical Advisory Board and engaged Dr. Fratellone as a distributor for Canbiola products. Dr. Fratellone is an attending physician at St. Luke's Hospital, Roosevelt Hospital, and Beth Israel Hospital, and current professor at University of Bridgeport College of Naturopathic Medicine. In addition, he bridges East Meets West at the Center of Excellence in Bridgeport CT with author Dr. Peter D'Adamo of Eat Right for Your Blood Type. Dr. Fratellone has appeared on multiple shows, and is considered an expert in his field as well a visionary. Dr. Fratellone stated, "As one of the few MDs in the US who is also a registered herbalist, I believe in traditional and time honored treatments, but also to look outside of the box; to that end CBD is certainly part of the future in my opinion with clear benefits to patients. I look forwarded to working with Canbiola, as well as educating the public on the vast benefits of CBD through blogs and speaking engagements."

FDA Grants ALRT Clearance for Insulin Dose Adjustment (IDA) Feature

Tue, 19 Sep 2017 10:02:29 EDT

IDA is designed to ensure that patients get an effective and timely insulin dose(s) based on accurate data about their specific needs

Pivot Pharma Looks to Improve Cannabinoid Bioavailability with Topical BiPhasix(TM) Delivery System -- CFN Media

Tue, 19 Sep 2017 09:00:00 EDT

SEATTLE, WA--(Marketwired - Sep 19, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article examining Pivot Pharmaceuticals Inc. (OTCQB: PVOTF) and its recent acquisition of the BiPhasixT Transdermal Drug Delivery technology for the delivery of cannabinoids.

Medovex Corporation Launches DenerveX System in Spain with Distributor Prim SA

Tue, 19 Sep 2017 08:30:00 EDT

Training and First Order Scheduled for Week of September 19th

Rennova Health Announces Big South Fork Medical Center Provided Services to Over 1,000 Patients in First Month of Operation

Tue, 19 Sep 2017 08:30:00 EDT

WEST PALM BEACH, FL--(Marketwired - September 19, 2017) - Rennova Health, Inc. (NASDAQ: RNVA) (NASDAQ: RNVAZ) ("Rennova" or the "Company"), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers, announces that Big South Fork Medical Center's Emergency Room has received 1,005 visits in its first month of operation and admitted 45 patients for overnight stays.

Cannabis Science "Nanoparticle Drones to Target Lung Cancer with Radiosensitizers and Cannabinoids" Full Publication Released Today In Frontiers In Oncology

Tue, 19 Sep 2017 08:18:05 EDT

IRVINE, CA--(Marketwired - Sep 19, 2017) -  Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, announces the full publication of initial research results on using nanoparticle drones to target lung cancer with radiosensitizers and cannabinoids in the world-renowned cancer research journal, Frontiers in Oncology, released today.

Graybug Vision Initiates Phase 1/2 Trial of GB-102 for Wet Age-related Macular Degeneration

Tue, 19 Sep 2017 08:00:00 EDT

Novel Injectable Formulation for Potential Twice Per Year Treatment

Pharmacology to Payer: One Quantitative Drug Development Framework to Rule Them All

Tue, 19 Sep 2017 07:30:00 EDT

TORONTO, ON--(Marketwired - September 19, 2017) - This webinar will discuss how "pharmacology to payer" (P2P) can be used as a quantitative framework that bridges the disciplines of pharmacology, epidemiology, and health economics to support meaningful dialogue between industry, regulators, and payers.

Biologics in Dermatology: Considerations for Patients and Clinical Trials, New Webinar Hosted by Xtalks

Tue, 19 Sep 2017 07:00:00 EDT

TORONTO, ON--(Marketwired - September 19, 2017) - In an upcoming presentation experts Darcee Duke Strube, Senior Vice President of Novella Clinical's Dermatology Division and Dr. James J Milbauer, Dermatologist, Medical Monitor and Advisor will discuss the evolution of biologics within the dermatology landscape, with an emphasis on clinical trial considerations for sponsors developing biologic agents.

Revive Therapeutics and South Carolina Research Foundation Enter into Exclusive License Agreement for Cannabinoids-Based Therapeutics in the Treatment of Liver Diseases

Tue, 19 Sep 2017 07:00:00 EDT

TORONTO, ONTARIO--(Marketwired - Sept. 19, 2017) - Revive Therapeutics Ltd. ("Revive" or the "Company") (TSX VENTURE:RVV)(OTCQB:RVVTF), a company focused on the research, development and commercialization of novel treatments for serious and unmet medical needs, today announced that it has entered into a license agreement with South Carolina Research Foundation ("SCRF"), under which Revive will acquire an exclusive license from SCRF to develop and commercialize a portfolio of patents based on cannabinoid-based therapeutics, such as Cannabidiol, in the treatment of liver diseases.

Medigus Announces Second Quarter 2017 Financial Results

Mon, 18 Sep 2017 16:05:00 EDT

OMER, ISRAEL--(Marketwired - Sep 18, 2017) - Medigus Ltd. (NASDAQ: MDGS) (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools and direct visualization technology, today announced financial results for the second quarter ended June 30, 2017.

Pressure BioSciences' Next-Generation Barocycler 2320EXTREME Named a Finalist in the Prestigious 2017 R&D 100 Awards

Mon, 18 Sep 2017 09:46:37 EDT

Considered Among the Most Prestigious Recognitions of Invention and Innovation Worldwide, the R&D 100 Awards Identify the Top 100 Revolutionary Technologies of the Past Year

GeoVax Provides Update on its Zika Vaccine Development

Mon, 18 Sep 2017 09:00:00 EDT

Presentation Made During 11th Vaccine Congress in San Diego

Amfil Technologies Inc.'s Snakes & Lattes Subsidiary To Begin Hosting Game Nights at the Rec Room Toronto Roadhouse, a Division of Cineplex Inc.

Mon, 18 Sep 2017 08:00:00 EDT

TORONTO, ON--(Marketwired - Sep 18, 2017) - Amfil Technologies Inc. (OTC PINK: AMFE) is pleased to announce the commencement date for Snakes & Lattes Game Nights at the Rec Room Toronto Roundhouse, beginning October 16th, 2017. The series of events, managed by Snakes & Lattes, will bring weekly board game nights to the Rec Room Toronto Roundhouse. On Mondays, from 7 PM - 11 PM EST, Rec Room guests are invited to take part in board gaming from a select library of titles curated and overseen by Snakes & Lattes Game Gurus.

MediXall Group, Inc. Creates Multiple Revenue Streams in September 2017

Mon, 18 Sep 2017 08:00:00 EDT

FT. LAUDERDALE, FL--(Marketwired - Sep 18, 2017) - MediXall Group, Inc. (OTCQB: MDXL) announced today that three additional revenue streams are in place and operational, creating additional value in the company. The mission of the MediXall Group is to revolutionize the medical industry by improving communication; providing better technology and support services; and enabling more efficient, cost-effective healthcare for the consumer. Prior to the planned October launch of the MediXaid Healthcare Platform, a subsidiary of MediXall Group with over 3,500 practitioners and diagnostic centers participating, to date, the company has signed agreements with strategic partners, SafeRide and PWeR®, who offer strong solutions to help network practitioners grow their businesses.

What Does it Take to Successfully Execute Large, Global, Phase III Programs?

Mon, 18 Sep 2017 07:30:00 EDT

TORONTO, ON--(Marketwired - September 18, 2017) - In a complimentary webinar taking place on Tuesday, October 3, 2017 at 10am EDT (3pm BST/UK), INC Research/inVentiv Health leaders Clifford McIntosh, Vice President of Strategic Alliance Management and Alexandria Wise-Rankovic, Ph.D., Senior Vice President of Clinical Development, CNS reveal a proven method to thrive in large, global, Phase III Programs.

Why Track and Trace Isn't Just Tracking and Tracing: Best Practices for Implementing a Solution That Works

Mon, 18 Sep 2017 07:00:00 EDT

TORONTO, ON--(Marketwired - September 18, 2017) - In an upcoming webinar on Wednesday, October 4, 2017, industry expert Joe Lipari, Director of Cloud Products at Systech International will discuss a holistic approach towards designing and achieving a successful Track and Trace solution.